Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

A Single-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)

Study ID: NCT07072689
Start Date: 2025-12-01
End Date: 2028-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment
Sponsor

Simonetti Giacomo

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Study ID: NCT07180862
Start Date: 2025-09-30
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

140

Intervention / Treatment

06

US-KEYTRUDA®

Sponsor

Bio-Thera Solutions

Source: clinicaltrials.gov

Share:
Add to list

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Study ID: NCT07146646
Start Date: 2025-10
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Trifluridine/tipiracil

Oxaliplatin

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Older Adults, Methadone, and Cognitive Function

Study ID: NCT07153029
Start Date: 2025-10-20
End Date: 2027-01-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Smartphone based cognitive tasks

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Cingal™ for Improving Pain Scores and Function in Anterior Knee Pain

Study ID: NCT05714397
Start Date: 2026-04
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Single

Sponsor

Banff Sport Medicine Foundation

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Study ID: NCT06801223
Start Date: 2025-10-30
End Date: 2028-05-20
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)

Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)

Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)

Sponsor

Innoviva Specialty Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

A Prospective Evaluation of Clinical Outcomes in Acute Ischemic Stroke After Endovascular Treatment w/Doppler

Study ID: NCT07013396
Start Date: 2025-10
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

TCD measurement

TCD parameters

Baseline characteristics

Clinical data will be collected

All follow-up patients receive a phone call

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list

Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk

Study ID: NCT03000803
Start Date: 2025-10
End Date: 2029-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Early Total Caloric Intake

Late Total Caloric Intake

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

Study ID: NCT06669403
Start Date: 2025-12
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

26

Intervention / Treatment

Opt101

Placebo

Sponsor

Op-T LLC

Source: clinicaltrials.gov

Share:
Add to list

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

Study ID: NCT06615973
Start Date: 2025-10-01
End Date: 2026-02-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment
Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Source: clinicaltrials.gov

Share:
Add to list